Predictive factors of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration in patients with gastric varices

American Journal of Gastroenterology

Volumn 104, Issue 9, 2009, Pages 2214-2221

  Elsamman, Mahmoud K ^a,b   Fujiwara, Yasuhiro ^a   Kameda, Natsuhiko ^a   Okazaki, Hirotoshi ^a   Tanigawa, Tetsuya ^a   Shiba, Masatsugu ^a   Tominaga, Kazunari ^a   Watanabe, Toshio ^a   Oshitani, Nobuhide ^a   Arafa, Usama A ^b   El Sayed, Adel A ^b   Nakamura, Kenji ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SOHAG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; IOPAMIDOL; MONOETHANOLAMINE OLEATE;

ADULT; AGED; ARTICLE; BALLOON OCCLUSION; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEMODYNAMIC PARAMETERS; HUMAN; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STOMACH VARICES;

ADULT; AGED; BALLOON DILATATION; DISEASE PROGRESSION; ENDOSONOGRAPHY; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGEAL DISEASES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 69949124292     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.140     Document Type: Article

References (47)

1. Sarin SK, Lahoti D, Saxena SP et al. Prevalence, classifi cation and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9.
2. Kanagawa H, Mima S, Kouyama H et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11: 51-8.
3. Schubert TT, Schnell GA, Walden JM. Bleeding from varices in the gastric fundus complicating sclerotherapy. Gastrointest Endosc 1989; 35: 268-9.
4. Kind R, Guglielmi A, Rodella L et al. Bucrylate treatment of bleeding gastric varices: 12 years experience. Endoscopy 2000; 32: 512-9.
5. Cello JP, Grendell JH, Crass RA et al. Endoscopic sclerotherapy vs. portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. N Engl J Med 1987; 3l6: 11-5.
6. Sarfeh IJ, Rypins EB. Th e emergent porta-caval H graft in alcohol cirrhotic patients: infl uence of shunt diameter on clinical outcome. Am J Surg 1986; 152: 290-3.
7. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126: 1175-89.
8. Rossle M, Haag K, Ochs A et al. Th e transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-71.
9. Sanyal AJ, Freedman AM, Luketic VA et al. Th e natural history of portal hypertension aft er transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-98.
10. Somberg KA. TIPS: safe, eff ective, better? Am J Gastroenterol 1997; 92: 1412-6.
11. Bureau C, Pagan JC, Layrargues GP et al. Patency of stents covered with polytetrafl uoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27: 742-7.
12. Barange K, P é ron JM, Imani K et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139-4.
13. Chau TN, Patch D, Chan YW et al. " Salvage " transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-7.
14. Hirota S, Matsumoto S, Tomita M et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211: 349-56.
15. Koito K, Namieno T, Nagakawa T et al. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. Am J Roentgenol 1996; 167: 1317-20.
16. Akahane T, Iwasaki T, Kobayashi N et al Changes in liver function parameters aft er occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92: 1026-30.
17. Kiyosue H, Mori H, Matsumoto S et al. Transcatheter obliteration of gastric varices. Part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23: 921-37.
18. Kanagawa H, Mima S, Kouyama H et al. A successfully treated case of fundic varices by retrograde transvenous obliteration with balloon [in Japanese]. Nippon Shokakibyo Gakkai Zasshi 1991; 88: 1459-62.
19. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327-36.
20. Kato T, Uematsu T, Nishigaki Y et al. Th erapeutic eff ect of balloonoccluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Intern Med 2001; 40: 688-91.
21. Matsumoto A, Hamamoto N, Kayazawa M. Balloon endoscopic sclerotherapy, a novel treatment for high-risk gastric fundal varices: a pilot study. Gastroenterology 1999; 117: 515-6.
22. Ninoi T, Nishida N, Kaminou T et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. Am J Roentgenol 2005; 184: 1340-6.
23. Kitamoto M, Imamura M, Kamada K et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. Am J Roentgenol 2002; 178: 1167-74.
24. Nakamura H, Endo M, Shimojuu K et al. Esophageal varices evaluated by endoscopic ultrasonography: observation of collateral circulation during non-shunting operations. Surg Endosc 1990; 4: 69-74.
25. Caletti GC, Brocchi E, Barnara L. Role of endoscopic ultrasonography in the treatment of esophageal varices. Endoscopy 1991; 23: 284-5.
26. Sato T, Yamazaki K, Toyota J et al. Evaluation of hemodynamics in esophageal varices: value of endoscopic color Doppler ultrasonography with a galactose-based contrast agent. Hepatol Res 2003; 25: 55-61.
27. Sato T, Yamazaki K, Toyota J et al. Observation of gastric variceal fl ow characteristics by endoscopic ultrasonography using color Doppler. Am J Gastroenterol 2008; 103: 575-80.
28. Kim T, Shijo H, Kokawa H et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25: 307-12.
29. Idezuki Y. General rules for recording endoscopic fi ndings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg 1995; 19: 420-2.
30. Moriyasu F, Nishida O, Ban N et al. " Congestion index " of the portal vein. Am J Roentgenol 1986; 146: 735-9.
31. Sabbá C, Weltin GG, Cicchetti DV et al. Observer variability in echo-Doppler measurements of portal fl ow in cirrhotic patients and normal volunteers. Gastroenterology 1990; 98: 1603-11.
32. Moriyasu F, Ban N, Nishida O et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood fl ow. J Clin Ultrasound 1986; 14: 579-88.
33. Hashizume M, Kitano S, Yamaga H et al. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988; 2: 340-1.
34. Konishi Y, Nakamura T, Kida H et al. Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence. Gastrointest Endosc 2002; 55: 197-203.
35. Sato T, Yamazaki K, Toyota J et al. Usefulness of electronic radial endoscopic color Doppler ultrasonography in esophageal varices: comparison with convex type. J Gastroenterol 2006; 41: 28-33.
36. Krogsgaard K, Gluud C, Henriksen JH et al. Correlation between liver morphology and portal pressure in alcoholic liver disease. Hepatology 1984; 4: 699-703.
37. Picchiotti R, Mingazzini PL, Scucchi L et al. Correlations between sinusoidal pressure and liver morphology in cirrhosis. J Hepatol 1994; 20: 364-9.
38. Braillon A, Cales P, Valla D et al. Infl uence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986; 27: 1204-9.
39. Hino S, Kakutani H, Ikeba K et al. Hemodynamic assessment of the left gastric vein in patients with esophageal varices with color Doppler EUS: factors aff ecting development of esophageal varices. Gastrointest Endosc 2002; 55: 512-7.
40. Matsutani S, Furuse J, Ishii H et al. Hemodynamics of the left gastric vein in portal hypertension. Gastroenterology 1993; 105: 513-8.
41. Hino S, Kakutani H, Ikeda K et al. Hemodynamic analysis of esophageal varices using color Doppler endoscopic ultrasonography to predict recurrence aft er endoscopic treatment. Endoscopy 2001; 33: 869-72.
42. Sato T, Yamazaki K, Toyota J et al. Evaluation of arterial blood fl ow in esophageal varices via endoscopic color Doppler ultrasonography with a galactose-based contrast agent. J Gastroenterol 2005; 40: 64-9.
43. Sato T, Yamazaki K, Toyota J et al. Perforating veins in recurrent esophageal varices evaluated by endoscopic color Doppler ultrasonography with a galactose-based contrast agent. J Gastroenterol 2004; 39: 422-8.
44. Polska E, Kircher K, Ehrlich P et al. RI in central retinal artery as assessed by CDI does not correspond to retinal vascular resistance. Am J Physiol Heart Circ Physiol 2001; 280: H1442-7.
45. Rifk in MD, Needleman L, Pasto ME et al. Evaluation of renal transplant rejection by duplex Doppler examination: value of the resistive index. Am J Roentgenol 1987; 148: 759-62.
46. Colli A, Cocciolo M, Mumoli N et al. Hepatic artery resistance in alcoholic liver disease. Hepatology 1998; 28: 1182-6.
47. Iwao T, Toyonaga A, Shigemori H et al. Hepatic artery hemodynamic responsiveness to altered portal blood fl ow in normal and cirrhotic livers. Radiology 1996; 200: 793-8.